Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 6, Issue 2, 2007, Pages 161-165

  Zuo, Huai Quan ^a   Yan, Lu Nan ^a   Zeng, Yong ^a   Yang, Jia Ying ^a   Luo, Hong Zhi ^a   Liu, Jiang Wen ^a   Zhou, Li Xin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Clinicopathological characteristics; Combined hepatocellular carcinoma and cholangiocarcinoma

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; HEPATITIS C ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BILE DUCT FISTULA; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; RECURRENT CANCER; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PORTAL VEIN; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 34047260120     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fukukura Y, Taguchi J, Nakashima O, Wada Y, Kojiro M. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features. J Comput Assist Tomogr 1997;21:52-58.
2. Allen RA, Lisa JR. Combined liver and bile duct carcinoma. Am J Pathol 1949;25:647-655.
3. Uenishi T, Hirohashi K, Shuto T, Tsukamoto T, Yamamoto T, Ogawa M, et al. Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers. Hepatogastroenterology 2002;49:1092-1094.
4. Asayama Y, Taguchi K, Aishima S, Nishi H, Masuda K, Tsuneyoshi M. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin. Liver 2002;22:43-50
5. Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea J, Robiou C, et al. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study. Am J Surg Pathol 2002;26:989-997.
6. Goodman Z, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular and cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985; 55:124-135.
7. Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, et al. combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J clin Oncol 2003;33:283-287.
8. Uenishi T, Hirohashi K, Shuto T, Tsukamoto T, Yamamoto T, Kubo S, et al. Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma. Hepatogastroenterology 2002;49:1083-1086.
9. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002;94:2040-2046.
10. Nishie A, Yoshimitsu K, Asayama Y, Irie H, Aibe H, Tajima T, et al. Detection of Combined hepatocellular and cholangiocarcinomas on Enhanced CT: Comparison with Histologic Findings. Am J Roentgenol 2005;184:1157-1162.
11. Ebied O, Federle MP, Blachar A, Brancatelli G, Grazioli L, Cazals-Hatem D, et al. Hepatocellular-cholangiocarcinoma: helical computed tomography findings in 30 patients. J Comput Assist Tomogr 2003;27:117-124.
12. He YM, Wang XY, Gao SD, Yu LY, Lin XD, Lin LW. Ultrasound-guided fine needle biopsy of intrahepatic nodules and low elevation of AFP in early diagnosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2005;4:50-54.
13. Torzilli G, Makuuchi M, Ferrero A, Takayama T, Hui AM, Abe H, et al. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients. Hepatogastroenterology 2002;49:740-745.
14. Liu CL, Fan ST, Lo CM, Ng IO, Lam CM, Poon RT, et al. Hepatic Resection for Combined Hepatocellular and Cholangiocarcinoma. Arch Surg 2003;138:86-90.
15. Sun LP, Zhou Y, Cao M, Cheng PH. An immunohistochemical study of mixed hepatocarcinoma. Chin J Dig 2002; 22:671-673.
16. Lucas M, Henrik P, Clavien PA. Surgical therapy of hepatocellular carcinoma. European J Gastroenterol Hepatol 2005;17:497-503.
17. Han SL, Zhu GB, Yao JG, Lan SH, Shao YF. Diagnosis and surgical treatment of primary hepatic cholangiocarcinoma. Hepatogastroenterology 2005;52:348-351.
18. Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004;5:722-732.
19. Giorgio E, Gian LG, R Matteo R, Walter FG, Matteo C, Andrea G, et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 2004;239:202-209.
20. Greten TF, Papendorf F, Bleck JS, Kirchhoff T, Wohlberedt T, Kubicka S, et al. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. British J Cancer 2005;92:1862-1868.
21. Akatsu T, Shimazu M, Kawachi S, Tanabe M, Aiura K, Wakabashi G, Ueda M, Sakamoto M, Kitajima M.Long-term survival of intrahepatic cholangiocarcinoma with hilar lymph node metastasis and portal vein involvement. Hepatogastroenterology 2005;52:603-605.
22. Koh KC, Lee H, Choi MS, Lee JH, Paik SW, Yoo BC, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005;189:120-125.
23. Shimada K, Sano T, Sakamoto Y, Kosuge T. A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy. Cancer 2005;104:1939-1947.